Toxicogenomics of nanoparticulate delivery of etoposide: potential impact on nanotechnology in retinoblastoma therapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1868-6966
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Toxicogenomics of nanoparticulate delivery of etoposide: potential impact on nanotechnology in retinoblastoma therapy ; volume:2 ; number:1-6 ; day:17 ; month:12 ; year:2010 ; pages:21-36 ; date:12.2011
Cancer nanotechnology ; 2, Heft 1-6 (17.12.2010), 21-36, 12.2011
- Creator
-
Mitra, Moutushy
- Contributor
-
Dilnawaz, Fahima
Misra, Ranjita
Harilal, Anju
Verma, Rama Shenkar
Sahoo, Sanjeeb K.
Krishnakumar, Subramanian
SpringerLink (Online service)
- DOI
-
10.1007/s12645-010-0010-4
- URN
-
urn:nbn:de:1111-201609059488
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mitra, Moutushy
- Dilnawaz, Fahima
- Misra, Ranjita
- Harilal, Anju
- Verma, Rama Shenkar
- Sahoo, Sanjeeb K.
- Krishnakumar, Subramanian
- SpringerLink (Online service)
Other Objects (12)
Erratum to: Toxicogenomics of nanoparticulate delivery of etoposide: potential impact on nanotechnology in retinoblastoma therapy
Expression changes and impact of the extracellular matrix on etoposide resistant human retinoblastoma cell lines
Nanotechnology-based drug delivery systems
Nanotechnology-based strategies overcoming the challenges of retinoblastoma: a comprehensive overview and future perspectives
Molecular mechanisms of etoposide
Stimuli‐Responsive Nanotechnology for RNA Delivery
Protein profiling of WERI-RB1 and etoposide-resistant WERI-ETOR reveals new insights into topoisomerase inhibitor resistance in retinoblastoma
Nanotechnology-based advances in the efficient delivery of melatonin
Effects of ascorbic acid on TRP channel-mediated Ca2+ homeostasis and cell viability in etoposide-resistant and -sensitive retinoblastoma cells
Different transcriptome profiles between human retinoblastoma Y79 cells and an etoposide-resistant subline reveal a chemoresistance mechanism
Nanotechnology-based drug delivery for the treatment of CNS disorders
Retrograde Approach for Intra-arterial Chemotherapy Delivery in Retinoblastoma
Erratum to: Toxicogenomics of nanoparticulate delivery of etoposide: potential impact on nanotechnology in retinoblastoma therapy
Expression changes and impact of the extracellular matrix on etoposide resistant human retinoblastoma cell lines
Nanotechnology-based drug delivery systems
Nanotechnology-based strategies overcoming the challenges of retinoblastoma: a comprehensive overview and future perspectives
Molecular mechanisms of etoposide
Stimuli‐Responsive Nanotechnology for RNA Delivery
Protein profiling of WERI-RB1 and etoposide-resistant WERI-ETOR reveals new insights into topoisomerase inhibitor resistance in retinoblastoma
Nanotechnology-based advances in the efficient delivery of melatonin
Effects of ascorbic acid on TRP channel-mediated Ca2+ homeostasis and cell viability in etoposide-resistant and -sensitive retinoblastoma cells
Different transcriptome profiles between human retinoblastoma Y79 cells and an etoposide-resistant subline reveal a chemoresistance mechanism
Nanotechnology-based drug delivery for the treatment of CNS disorders
Retrograde Approach for Intra-arterial Chemotherapy Delivery in Retinoblastoma
Erratum to: Toxicogenomics of nanoparticulate delivery of etoposide: potential impact on nanotechnology in retinoblastoma therapy
Expression changes and impact of the extracellular matrix on etoposide resistant human retinoblastoma cell lines
Nanotechnology-based drug delivery systems
Nanotechnology-based strategies overcoming the challenges of retinoblastoma: a comprehensive overview and future perspectives
Molecular mechanisms of etoposide
Stimuli‐Responsive Nanotechnology for RNA Delivery
Protein profiling of WERI-RB1 and etoposide-resistant WERI-ETOR reveals new insights into topoisomerase inhibitor resistance in retinoblastoma
Nanotechnology-based advances in the efficient delivery of melatonin
Effects of ascorbic acid on TRP channel-mediated Ca2+ homeostasis and cell viability in etoposide-resistant and -sensitive retinoblastoma cells
Different transcriptome profiles between human retinoblastoma Y79 cells and an etoposide-resistant subline reveal a chemoresistance mechanism
Nanotechnology-based drug delivery for the treatment of CNS disorders